Clinical trial
CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response…
NCT00122772 · International Atomic Energy Agency, Other · Completed
Key facts
| NCT number | NCT00122772 |
|---|---|
| Title | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy |
| Official title | CRP on Radiobiological and Clinical Studies on Viral-induced Cancer's Response to Radiotherapy With Comprehensive Morbidity Assessment |
| Lead sponsor | International Atomic Energy Agency, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervix Cancer |
| Intervention type | Radiation |
| Interventions | Radiotherapy, Radiotherapy/Cisplatin |
| Enrollment | 601 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jul 22, 2005 |
| Last update posted | Oct 14, 2011 |
| Countries | Austria, Brazil, Canada, India, Morocco, North Macedonia, Pakistan, Peru, South Africa, South Korea, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: